Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/gilgamesh-announces-initiation-of-phase-2a-trial-of-gm-1020-in-major-depressive-disorder-302132468.html
https://www.prnewswire.com/news-releases/gilgamesh-pharmaceuticals-awarded-14-million-national-institute-on-drug-abuse-grant-to-advance-novel-cardiac-safe-ibogaine-analog-for-the-treatment-of-opioid-use-disorder-302089598.html
https://www.prnewswire.com/news-releases/gilgamesh-pharmaceuticals-successfully-completes-phase-1-sadmad-clinical-trials-of-gm-1020-301934271.html